Evidence map›Paper›PMID 40366171›Full record

ReviewJournal of virology2025

Phage therapy: a promising approach for

Lucile Plumet, Chloé Magnan, Denis Costechareyre, Albert Sotto, Jean-Philippe Lavigne, Virginie Molle

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lucile PlumetVBIC, INSERM U1047, University of Montpellier, Montpellier, France.ORCID 0000-0002-2128-8010
Chloé MagnanVBIC, INSERM U1047, University of Montpellier, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Nîmes, France.
Denis CostechareyreGreenphage, Cap Alpha, Clapiers, France.
Albert SottoVBIC, INSERM U1047, University of Montpellier, Department of Infectious Diseases, CHU Nîmes, Nîmes, France.
Jean-Philippe LavigneVBIC, INSERM U1047, University of Montpellier, Department of Microbiology and Hospital Hygiene, CHU Nîmes, Nîmes, France.ORCID 0000-0002-9484-0304
Virginie MolleVBIC, INSERM U1047, University of Montpellier, Montpellier, France.ORCID 0000-0002-6573-3411

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic foot infections (DFIs), predominantly caused by

Indexed as

Diabetic FootPhage TherapyStaphylococcal InfectionsStaphylococcus aureusAnimalsAnti-Bacterial AgentsBacteriophagesDisease Models, AnimalHumansWound HealingAnti-Bacterial Agentsanimal modelsbacteriophagesclinical casesclinical trialsdiabetic foot infectionsphage therapyStaphylococcus aureus

Identifiers

PMID40366171
PMCPMC12172479

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.